We provide you with 20 years of free, institutional-grade data for CGC stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CGC. Explore the full financial landscape of CGC stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about CGC stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Canopy Growth Corporation(NASDAQ:CGC) 
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer ...
Website: http://www.canopygrowth.com
Founded: 2013
Full Time Employees: 4,434
CEO: David Klein
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic